Nephros

About:

Nephros develops water purification products and pathogen detection systems for the medical and commercial markets.

Website: http://nephros.com

Twitter/X: nephrosinc

Description:

Nephros is a commercial-stage company that develops and sells high-performance water purification products to the medical device and commercial markets. The company ultrafilters used in hospitals and medical clinics for added protection in retaining bacteria (e.g., Legionella, Pseudomonas) and viruses from water, providing barriers that assist in improving infection control in showers, sinks, and ice machines. Additionally, Nephros ultrafilters also used by dialysis centers for assisting in the added removal of endotoxins and other biological contaminants from the water and bicarbonate concentrate supplied to hemodialysis machines and patients. The company was founded in 1997 and is based in South Orange, New Jersey, United States.

Total Funding Amount:

$12.5M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

South Orange, New Jersey, United States

Founded Date:

1997-01-01

Contact Email:

info(AT)nephros.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2021-07-13

IPO Status:

Public

Industries:

© 2025 bioDAO.ai